Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC 5 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: BIOSANTE PHARM -- BPAX 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: BPAX , CYTX , MNTA , NVAX , TTNP , TRMS , XNPT -- DRUGS 3 $4 View Abstract
4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Biosante Pharmaceuticals, Inc. 41 $65 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for BPAX: the economy's impact on BPAX's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC 5 $25 View Abstract
26-Jan-10 Zacks Investment Research Inc. N/A BIOSANTE PHARMA (BPAX) Zacks Company Snapshot 1 $10 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC 5 $25 View Abstract
Next 12

Independent Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary) 34 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Nanotechnology & MEMS Industry Market Research and Competitive Analysis 2009 447 $299 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC 5 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: BIOSANTE PHARM -- BPAX 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: BPAX , CYTX , MNTA , NVAX , TTNP , TRMS , XNPT -- DRUGS 3 $4 View Abstract
4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Biosante Pharmaceuticals, Inc. 41 $65 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for BPAX: the economy's impact on BPAX's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC 5 $25 View Abstract
26-Jan-10 Zacks Investment Research Inc. N/A BIOSANTE PHARMA (BPAX) Zacks Company Snapshot 1 $10 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOSANTE PHARMACEUTICALS INC 5 $25 View Abstract
Next 12

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.